Synopex Q1 2026: Revenue and Profit Decline, Improved Financial Structure and Subsidiary Merger

Consolidated revenue in Q1 2026: 57.2B won, down 14.9% YoY (67.3B)
Consolidated operating profit: 1.3B won, significantly down from 6.8B in Q1 2025
Separate operating loss of 2.9B won vs profit of 2.1B won in Q1 2025
Consolidated net income: 3.0B won, down 47% from 5.7B in Q1 2025
EPS: 33 won (vs 62 won)
Debt ratio improved to 50.55%, net cash position maintained
R&D expenditure ratio increased to 6.24% of sales (from 4.90%)
Board resolved merger with subsidiary Synopex Membrane (merger date June 29, 2026)
EV battery FPCB module sample supply ongoing; dialysis devices localization progressing
No dividends or share buyback/s cancellation in the quarter